Terns’ third quarter cash balance as of September 30, 2024, was $372.8 million which is expected to provide cash runway into 2028. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on TERN: Terns Pharmaceuticals Appoints Andrew Gengos as CFO Terns Pharmaceuticals appoints Andrew Gengos as CFO Terns Pharmaceuticals Appoints Robert Azelby to Board Terns Pharmaceuticals CFO Resignation and Leadership Transition Novartis CEO discusses search for obesity deals with WSJ
